Moderna begins coronavirus vaccine trial

The US biotech Moderna was just about the only stock on the rise yesterday amid the global COVID-19 bear market, as the Massachusetts firm announced the first patient had been tested with i

Pharma staff told to work at home as Biogen deals with coron...

The coronavirus has begun to affect day-to-day operations at pharma companies, with Biogen dealing with an outbreak linked to a management meeting at an affected hotel, and others telling s

Takeda and Arcturus join hunt for coronavirus therapies

The Japanese drugs giant Takeda and the US biotech Arcturus Therapeutics have joined the hunt for therapies for the COVID-19 coronavirus.

Chinese biotech censured for misleading coronavirus drug cla...

China’s BrightGene Bio-Medical Technology has been censured by the Shanghai Stock Exchange for wrongly claiming it is able to manufacture Gilead’s experimental drug remdesivir – scientists’

GSK teams up with Clover on coronavirus vaccine

Moderna shares slide after record $604m US listing

RNA drug specialist Moderna smashed the record for an initial public offering (IPO) in the US on Friday, raising a whopping $604 million, although its shares retreated 19% after the debut.